From the resultant dataset, we selected those with stock prices under $10 and ranked them ... MannKind Corporation (NASDAQ:MNKD) develops inhaled therapies for diabetes, with Afrezza as its ...

Proficio Capital Partners LLC acquired a new stake in shares of MannKind Co. (NASDAQ:MNKD – Free Report) in the fourth ...

Investors eyeing a purchase of MannKind Corp (Symbol: MNKD) stock, but tentative about paying the going market price of $4.96/share, might benefit from considering selling puts among the ...

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Sarepta Therapeutics (SRPT – Research Report), ...

Participation from Market Makers and ECNs is strictly voluntary and as a result, these sessions may offer less liquidity and inferior prices. Stock prices may also move more quickly in this ...

Short interest in MannKind Corp (NASDAQ:MNKD) increased during the last reporting ... to close out their positions without sending the stock sharply higher.